International Ovarian & Testicular Stromal Tumor Registry

Plain-language summary

This is an international registry study that follows patients with ovarian and testicular stromal tumors. It includes people diagnosed with ovarian or testicular stromal tumors such as Sertoli-Leydig cell tumor or juvenile granulosa cell tumor. The study is a non-phase study and is currently recruiting.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Recruiting

Sponsor

Children's Hospitals and Clinics of Minnesota

Start date

12/8/2011

Estimated completion

12/1/2030

Countries

United States

Related genes

Locations

• Minneapolis, United States

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Previous or current diagnosis of an ovarian sex cord stromal including but not limited to: Sertoli-Leydig cell tumor, gynandroblastoma (now enrolling these patients on PPB/DICER1 Registry), juvenile granulosa cell tumor, Sertoli cell tumor, sex cord-stromal tumor with annular tubules or undifferentiated stromal tumor
* Previous or current diagnosis of a testicular stromal tumor including but not limited to: juvenile granulosa cell tumor, Sertoli cell tumor, Leydig cell tumor or undifferentiated stromal tumor

Exclusion Criteria:

* Unable to provide informed consent/assent
* Adult Granulosa cell tumor (unless otherwise specified by Medical Director)